Kevzara pen

Kevzara Pen is a prescription medication that is used to treat adult patients suffering from rheumatoid arthritis. It is an injection that contains the active ingredient sarilumab, which belongs to a class of drugs called interleukin-6 (IL-6) inhibitors. This medication works by blocking the action of IL-6, a substance in the body that causes inflammation.

Dosage and Administration:

Kevzara Pen is available as a pre-filled pen that is injected subcutaneously (under the skin) once every two weeks. The recommended dose is 200 mg. Patients should follow the injection instructions provided by their healthcare provider carefully. The injection site should be rotated between the thighs, abdomen, or outer area of the upper arm, and the injection should not be given into areas where the skin is tender, bruised, red, or hard.

Uses:

Kevzara Pen is used to treat rheumatoid arthritis in adult patients who have not responded well to other treatments. Rheumatoid arthritis is a chronic autoimmune disease that causes inflammation and pain in the joints, leading to stiffness and difficulty in movement. By blocking IL-6, Kevzara Pen helps to reduce inflammation in the joints, thereby reducing pain and improving mobility.

Precautions and Contraindications:

Before taking Kevzara Pen, patients should inform their healthcare provider about any medical conditions they have, including allergies, infections, or a history of cancer. This medication may increase the risk of serious infections, including tuberculosis, so patients should be monitored closely for signs of infection during treatment. Patients who have an active infection or a history of recurrent infections should not take Kevzara Pen.

Kevzara Pen should not be taken with live vaccines or with other biologic medications that also suppress the immune system. Pregnant and breastfeeding women should also not take Kevzara Pen.

Side Effects:

The most common side effects of Kevzara Pen include injection site reactions, such as pain, redness, swelling, or itching. Patients may also experience upper respiratory tract infections, urinary tract infections, or an increase in cholesterol levels. Rare but serious side effects may include allergic reactions, liver damage, or a decrease in white blood cell counts.

It is essential for patients to inform their healthcare provider immediately if they experience any unusual symptoms while taking Kevzara Pen.

Conclusion:

Kevzara Pen is a medication that is used to treat rheumatoid arthritis in adult patients. It works by blocking IL-6, a substance in the body that causes inflammation. Patients should follow the injection instructions carefully and inform their healthcare provider about any medical conditions they have. The most common side effects of Kevzara Pen include injection site reactions and upper respiratory tract infections. Patients should inform their healthcare provider immediately if they experience any unusual symptoms while taking Kevzara Pen.